Exelixis (EXEL) Revenue (2010 - 2026)
Exelixis (EXEL) reported Revenue of $628.69 million for Q2 2027, up 10.6% from $568.26 million a year earlier and up 2.9% from the prior quarter.
Powered by 
Analysis
Exelixis (EXEL) Revenue (2010 - 2026) Analysis & Trends
Over the twelve months ended Jul 3, 2026, Exelixis' Revenue came in at $2.44 billion, up 9.2% year-over-year; for FY2026, it came in at $2.32 billion, up 7.0% from FY2025.
- Revenue has a five-year compound annual growth rate of 10.1% (FY2021 to FY2026).
- By year, Revenue came in at $2.17 billion in FY2025, $1.83 billion in FY2023 (+13.6%) and $1.61 billion in FY2022 (+12.3%).
- The Q2 2027 figure ranks as the highest quarterly Revenue since Q2 2025.
- Year over year, Revenue has now increased in each of the last four quarters, with growth averaging 9.5% over the last six quarters.
- Per Business Quant data, the three quarters before Q2 2027 came in at $610.81 million (Q1 2027), $598.66 million (Q4 2026) and $597.76 million (Q3 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 3.33 Bn |
| 10 | Exelixis | 14.60 Bn | 10.93 Bn | 608.03 Mn | 628.69 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 3, 2026 | 628.69 Mn |
| Apr 3, 2026 | 610.81 Mn |
| Jan 2, 2026 | 598.66 Mn |
| Oct 3, 2025 | 597.76 Mn |
| Jul 4, 2025 | 568.26 Mn |
| Apr 4, 2025 | 555.45 Mn |
| Jan 3, 2025 | 566.76 Mn |
| Sep 27, 2024 | 539.54 Mn |
| Jun 28, 2024 | 637.18 Mn |
| Mar 29, 2024 | 425.23 Mn |
| Dec 29, 2023 | 479.65 Mn |
| Sep 29, 2023 | 471.92 Mn |
| Jun 30, 2023 | 469.85 Mn |
| Mar 31, 2023 | 408.79 Mn |
| Dec 30, 2022 | 423.92 Mn |
| Sep 30, 2022 | 411.74 Mn |
| Jul 1, 2022 | 419.43 Mn |
| Apr 1, 2022 | 355.98 Mn |
| Oct 1, 2021 | 328.42 Mn |
| Jul 2, 2021 | 385.18 Mn |
API Access
Exelixis Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=EXEL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "EXEL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=EXEL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();